XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Beginning balance at Dec. 31, 2023 $ 10,815.3 $ 216.7 $ 7,297.8 $ 4,052.9 $ (792.1) $ 40.0
Beginning balance (in shares) at Dec. 31, 2023   216.7        
Net earnings 612.7     608.4   4.3
Net purchase of subsidiary shares from noncontrolling interests (0.3)         (0.3)
Dividends paid to noncontrolling interests (0.6)         (0.6)
Net change in pension asset/liability, net of taxes 0.3       0.3  
Foreign currency translation (155.8)       (155.8)  
Change in fair value of derivative instruments, net of taxes (1.4)       (1.4)  
Compensation expense related to stock option plan grants 15.1   15.1      
Common stock issued in:            
Purchase transaction 88.3 $ 0.4 87.9      
Purchase transactions (in shares)   0.4        
Stock option plans 39.9 $ 0.6 39.3      
Stock option plans (in shares)   0.6        
Employee stock purchase plan 12.2 $ 0.1 12.1      
Employee stock purchase plan (in shares)   0.1        
Shares issued to benefit plans 98.5 $ 0.4 98.1      
Shares issued to benefit plans (in shares)   0.4        
Deferred compensation and restricted stock (48.0) $ 0.3 (48.3)      
Deferred compensation and restricted stock (in shares)   0.3        
Cash dividends declared on common stock (132.0)     (132.0)    
Ending balance at Mar. 31, 2024 11,344.2 $ 218.5 7,502.0 4,529.3 (949.0) 43.4
Ending balance, (in shares) at Mar. 31, 2024   218.5        
Beginning balance at Dec. 31, 2023 10,815.3 $ 216.7 7,297.8 4,052.9 (792.1) 40.0
Beginning balance (in shares) at Dec. 31, 2023   216.7        
Net earnings 898.1          
Net change in pension asset/liability, net of taxes 0.2          
Ending balance at Jun. 30, 2024 11,599.3 $ 219.1 7,611.4 4,681.2 (939.2) 26.8
Ending balance, (in shares) at Jun. 30, 2024   219.1        
Beginning balance at Mar. 31, 2024 11,344.2 $ 218.5 7,502.0 4,529.3 (949.0) 43.4
Beginning balance (in shares) at Mar. 31, 2024   218.5        
Net earnings 285.4     283.4   2.0
Net purchase of subsidiary shares from noncontrolling interests (18.4)         (18.4)
Dividends paid to noncontrolling interests (0.3)         (0.3)
Net change in pension asset/liability, net of taxes (0.1)       (0.1)  
Foreign currency translation 11.4       11.3 0.1
Change in fair value of derivative instruments, net of taxes (1.4)       (1.4)  
Compensation expense related to stock option plan grants 10.5   10.5      
Common stock issued in:            
Purchase transaction 45.5 $ 0.2 45.3      
Purchase transactions (in shares)   0.2        
Stock option plans 24.8 $ 0.3 24.5      
Stock option plans (in shares)   0.3        
Employee stock purchase plan 16.5 $ 0.0 16.5      
Employee stock purchase plan (in shares)   0.0        
Deferred compensation and restricted stock 12.7 $ 0.1 12.6      
Deferred compensation and restricted stock (in shares)   0.1        
Cash dividends declared on common stock (131.5)     (131.5)    
Ending balance at Jun. 30, 2024 11,599.3 $ 219.1 7,611.4 4,681.2 (939.2) 26.8
Ending balance, (in shares) at Jun. 30, 2024   219.1        
Beginning balance at Dec. 31, 2024 $ 20,179.6 $ 250.0 16,068.9 4,985.7 (1,151.1) 26.1
Beginning balance (in shares) at Dec. 31, 2024 250.0 250.0        
Net earnings $ 708.9     704.4   4.5
Net purchase of subsidiary shares from noncontrolling interests 3.0         3.0
Net change in pension asset/liability, net of taxes (0.1)       (0.1)  
Foreign currency translation 217.3       217.3  
Change in fair value of derivative instruments, net of taxes (0.1)       (0.1)  
Compensation expense related to stock option plan grants 17.8   17.8      
Common stock issued in:            
Purchase transaction 16.6 $ 0.1 16.5      
Purchase transactions (in shares)   0.1        
Stock option plans 68.6 $ 0.7 67.9      
Stock option plans (in shares)   0.7        
Employee stock purchase plan 14.1 $ 0.1 14.0      
Employee stock purchase plan (in shares)   0.1        
Stock issuance from public offering 1,252.1 $ 4.6 1,247.5      
Stock issuance from public offering (in shares)   4.6        
Shares issued to benefit plans 119.6 $ 0.3 119.3      
Shares issued to benefit plans (in shares)   0.3        
Deferred compensation and restricted stock (76.5) $ 0.3 (76.8)      
Deferred compensation and restricted stock (in shares)   0.3        
Cash dividends declared on common stock (167.2)     (167.2)    
Ending balance at Mar. 31, 2025 22,353.7 $ 256.1 17,475.1 5,522.9 (934.0) 33.6
Ending balance, (in shares) at Mar. 31, 2025   256.1        
Beginning balance at Dec. 31, 2024 $ 20,179.6 $ 250.0 16,068.9 4,985.7 (1,151.1) 26.1
Beginning balance (in shares) at Dec. 31, 2024 250.0 250.0        
Net earnings $ 1,075.1          
Net change in pension asset/liability, net of taxes $ (4.7)          
Common stock issued in:            
Stock option plans (in shares) 1.0          
Ending balance at Jun. 30, 2025 $ 23,056.3 $ 256.4 17,546.3 5,720.7 (500.3) 33.2
Ending balance, (in shares) at Jun. 30, 2025 256.4 256.4        
Beginning balance at Mar. 31, 2025 $ 22,353.7 $ 256.1 17,475.1 5,522.9 (934.0) 33.6
Beginning balance (in shares) at Mar. 31, 2025   256.1        
Net earnings 366.2     365.8   0.4
Net purchase of subsidiary shares from noncontrolling interests (0.8)         (0.8)
Net change in pension asset/liability, net of taxes (4.6)       (4.6)  
Foreign currency translation 427.6       427.6  
Change in fair value of derivative instruments, net of taxes 10.7       10.7  
Compensation expense related to stock option plan grants 11.6   11.6      
Common stock issued in:            
Stock option plans 23.9 $ 0.2 23.7      
Stock option plans (in shares)   0.2        
Employee stock purchase plan 19.8 $ 0.1 19.7      
Employee stock purchase plan (in shares)   0.1        
Deferred compensation and restricted stock 16.2 $ 0.0 16.2      
Deferred compensation and restricted stock (in shares)   0.0        
Cash dividends declared on common stock (168.0)     (168.0)    
Ending balance at Jun. 30, 2025 $ 23,056.3 $ 256.4 $ 17,546.3 $ 5,720.7 $ (500.3) $ 33.2
Ending balance, (in shares) at Jun. 30, 2025 256.4 256.4